Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Effects of Therapeutic Doses of Celecoxib on Several Physiological Parameters of Cultured Human Osteoblasts
The osteocyte: A multifunctional cell within the bone
Hip fractures following denosumab discontinuation: three clinical cases reports
A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients
Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study
Analysis of volumetric BMD in people with Down syndrome using DXA-based 3D modeling
Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone
2019 Jul 4;127:482-487. doi: 10.1016/j.bone.2019.07.003 PubMed PMID: 31280018. Vom Scheidt A, Hemmatian H, Püschel K, Krause M, Amling M, Busse B. Bone.
2019 Jun 26;127:250-259. doi: 10.1016/j.bone.2019.06.014 PubMed PMID: 31254731 Iki M, Fujita Y, Kouda K, Yura A, Tachiki T, Tamaki J, Sato Y, Moon JS, Hamada M, Kajita E, Okamoto N, Kurumatani N Bone.